Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Efficacy of short-term interferon therapy for patients infected with hepatitis C virus genotype 2a.

The American journal of gastroenterology - 1 Apr 2005

Tabaru Akinari, Narita Ryoichi, Hiura Masaaki, Abe Shintaro, Otsuki Makoto

Abstract excerpt

BACKGROUND AND AIMS: The efficacy of interferon (IFN)-based antiviral therapy for chronic hepatitis C (CHC) varies depending on predictive factors such as hepatitis C virus (HCV) genotype and viral load. For patients with good predictive factors, a low dose and short course of IFN-based therapy may be adequate. However, there is no evidence about the optimal duration of IFN-based therapy for these patients. The...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Interferon-alpha
Share to Drug Administration Schedule

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis C, Chronic

Share to Injections, Intramuscular

Share to Interferon alpha-2

Share to Liver Function Tests

Share to Long-Term Care

Share to Viral Load

Source

Identifiers

PMID: 15784033
DOI: 10.1111/j.1572-0241.2005.40826.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Efficacy of short-term interferon therapy for patients infected with hepatitis C virus genotype 2a.PMID 15784033Read ↗

The efficacy of short-term interferon-beta therapy for chronic hepatitis C patients with low virus load.Semantic proximity Read ↗

The efficacy of short-term interferon-beta therapy for type C cirrhotic patients with genotype 2a and low virus load.Semantic proximity Read ↗

Short-term therapy for patients with hepatitis C virus genotype 2 or 3 infection.Semantic proximity Read ↗

[Short-term therapy with pegylated interferon plus ribavirin for the chronic hepatitis C genotype 2 patients].Semantic proximity Read ↗

Predictive factors of a response to interferon therapy in chronic hepatitis C.Semantic proximity Read ↗

Long-term efficacy of interferon therapy in patients with chronic hepatitis B virus infection in Japan.Semantic proximity Read ↗

Efficacy of long-term interferon therapy in chronic hepatitis B patients with HBV genotype C.Semantic proximity Read ↗

Extended-therapy duration for chronic hepatitis C, genotype 1: the long and the short of it.Semantic proximity Read ↗

Short- and long-term outcome of interferon therapy for chronic hepatitis B infection.Semantic proximity Read ↗

Clinical trial: extended treatment duration of peginterferon-alpha2b plus ribavirin for 72 and 96 weeks in hepatitis C genotype 1-infected late responders.Semantic proximity Read ↗

A 48-week duration of therapy with pegylated interferon alpha 2b plus ribavirin may be too short to maximize long-term response among patients infected with genotype-1 hepatitis C virus.Semantic proximity Read ↗

Short versus standard treatment with pegylated interferon alfa-2A plus ribavirin in patients with hepatitis C virus genotype 2 or 3: the cleo trial.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.